183 related articles for article (PubMed ID: 14603443)
1. The role of late/slow replication of the FRA16D in common fragile site induction.
Palakodeti A; Han Y; Jiang Y; Le Beau MM
Genes Chromosomes Cancer; 2004 Jan; 39(1):71-6. PubMed ID: 14603443
[TBL] [Abstract][Full Text] [Related]
2. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors.
Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM
Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991
[TBL] [Abstract][Full Text] [Related]
3. Common chromosomal fragile sites and cancer: focus on FRA16D.
O'Keefe LV; Richards RI
Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
[TBL] [Abstract][Full Text] [Related]
4. Common fragile sites and cancer (review).
Smith DI; Huang H; Wang L
Int J Oncol; 1998 Jan; 12(1):187-96. PubMed ID: 9454904
[TBL] [Abstract][Full Text] [Related]
5. Common chromosomal fragile site FRA16D mutation in cancer cells.
Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
[TBL] [Abstract][Full Text] [Related]
6. Components of DNA damage checkpoint pathway regulate UV exposure-dependent alterations of gene expression of FHIT and WWOX at chromosome fragile sites.
Ishii H; Mimori K; Inageta T; Murakumo Y; Vecchione A; Mori M; Furukawa Y
Mol Cancer Res; 2005 Mar; 3(3):130-8. PubMed ID: 15798093
[TBL] [Abstract][Full Text] [Related]
7. Stably transfected common fragile site sequences exhibit instability at ectopic sites.
Ragland RL; Glynn MW; Arlt MF; Glover TW
Genes Chromosomes Cancer; 2008 Oct; 47(10):860-72. PubMed ID: 18615677
[TBL] [Abstract][Full Text] [Related]
8. Replication timing of two human common fragile sites: FRA1H and FRA2G.
Pelliccia F; Bosco N; Curatolo A; Rocchi A
Cytogenet Genome Res; 2008; 121(3-4):196-200. PubMed ID: 18758159
[TBL] [Abstract][Full Text] [Related]
9. The characterization of the common fragile site FRA16D and its involvement in multiple myeloma translocations.
Krummel KA; Roberts LR; Kawakami M; Glover TW; Smith DI
Genomics; 2000 Oct; 69(1):37-46. PubMed ID: 11013073
[TBL] [Abstract][Full Text] [Related]
10. Replication of a common fragile site, FRA3B, occurs late in S phase and is delayed further upon induction: implications for the mechanism of fragile site induction.
Le Beau MM; Rassool FV; Neilly ME; Espinosa R; Glover TW; Smith DI; McKeithan TW
Hum Mol Genet; 1998 Apr; 7(4):755-61. PubMed ID: 9499431
[TBL] [Abstract][Full Text] [Related]
11. Molecular parameters of genome instability: roles of fragile genes at common fragile sites.
Pichiorri F; Ishii H; Okumura H; Trapasso F; Wang Y; Huebner K
J Cell Biochem; 2008 Aug; 104(5):1525-33. PubMed ID: 18393361
[TBL] [Abstract][Full Text] [Related]
12. The common fragile site FRA16D and its associated gene WWOX are highly conserved in the mouse at Fra8E1.
Krummel KA; Denison SR; Calhoun E; Phillips LA; Smith DI
Genes Chromosomes Cancer; 2002 Jun; 34(2):154-67. PubMed ID: 11979549
[TBL] [Abstract][Full Text] [Related]
13. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
[TBL] [Abstract][Full Text] [Related]
14. SMC1 inhibition results in FRA3B expression but has no effect on its delayed replication.
Focarelli ML; Montagna C; Colombo R; Ried T; Vezzoni P; Musio A
Mutat Res; 2006 Mar; 595(1-2):23-8. PubMed ID: 16242161
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal fragile site FRA16D and DNA instability in cancer.
Mangelsdorf M; Ried K; Woollatt E; Dayan S; Eyre H; Finnis M; Hobson L; Nancarrow J; Venter D; Baker E; Richards RI
Cancer Res; 2000 Mar; 60(6):1683-9. PubMed ID: 10749140
[TBL] [Abstract][Full Text] [Related]
16. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
[TBL] [Abstract][Full Text] [Related]
17. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
18. WWOX, the common chromosomal fragile site, FRA16D, cancer gene.
Ludes-Meyers JH; Bednarek AK; Popescu NC; Bedford M; Aldaz CM
Cytogenet Genome Res; 2003; 100(1-4):101-10. PubMed ID: 14526170
[TBL] [Abstract][Full Text] [Related]
19. Critical steps for induction of chromosomal aberrations in CHO cells heated in S phase.
Wong RS; Kapp LN; Krishnaswamy G; Dewey WC
Radiat Res; 1993 Jan; 133(1):52-9. PubMed ID: 8434113
[TBL] [Abstract][Full Text] [Related]
20. Concordant loss of fragile gene expression early in breast cancer development.
Guler G; Uner A; Guler N; Han SY; Iliopoulos D; McCue P; Huebner K
Pathol Int; 2005 Aug; 55(8):471-8. PubMed ID: 15998374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
